BR112012024835A2 - adesivo de distribuição transdérmica - Google Patents
adesivo de distribuição transdérmicaInfo
- Publication number
- BR112012024835A2 BR112012024835A2 BR112012024835A BR112012024835A BR112012024835A2 BR 112012024835 A2 BR112012024835 A2 BR 112012024835A2 BR 112012024835 A BR112012024835 A BR 112012024835A BR 112012024835 A BR112012024835 A BR 112012024835A BR 112012024835 A2 BR112012024835 A2 BR 112012024835A2
- Authority
- BR
- Brazil
- Prior art keywords
- transdermal patch
- patch adhesive
- adhesive
- transdermal
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J7/00—Adhesives in the form of films or foils
- C09J7/20—Adhesives in the form of films or foils characterised by their carriers
- C09J7/22—Plastics; Metallised plastics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D133/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
- C09D133/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D139/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Coating compositions based on derivatives of such polymers
- C09D139/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
- C09D139/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
- C08K5/0058—Biocides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/49—Phosphorus-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J2301/00—Additional features of adhesives in the form of films or foils
- C09J2301/40—Additional features of adhesives in the form of films or foils characterized by the presence of essential components
- C09J2301/41—Additional features of adhesives in the form of films or foils characterized by the presence of essential components additives as essential feature of the carrier layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
adesivo de distribuição transdérmica. uma composição apropriada para uso em um adesivo de distribuição transdérmica para administração de um composto biologicamente ativo, a composição compreendendo um composto de fosfato de tocoferol e um veículo de polímero.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31900710P | 2010-03-30 | 2010-03-30 | |
US31900210P | 2010-03-30 | 2010-03-30 | |
PCT/AU2011/000358 WO2011120084A1 (en) | 2010-03-30 | 2011-03-30 | Transdermal delivery patch |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012024835A2 true BR112012024835A2 (pt) | 2016-06-07 |
Family
ID=44711223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012024835A BR112012024835A2 (pt) | 2010-03-30 | 2011-03-30 | adesivo de distribuição transdérmica |
Country Status (17)
Country | Link |
---|---|
US (4) | US8652511B2 (pt) |
EP (1) | EP2552486B1 (pt) |
JP (1) | JP5806287B2 (pt) |
KR (1) | KR20130010473A (pt) |
CN (1) | CN102821791B (pt) |
AU (1) | AU2011235597B2 (pt) |
BR (1) | BR112012024835A2 (pt) |
CA (1) | CA2794734C (pt) |
ES (1) | ES2829386T3 (pt) |
IL (1) | IL222226A (pt) |
MX (1) | MX2012011355A (pt) |
NZ (1) | NZ602572A (pt) |
RU (1) | RU2553350C2 (pt) |
SG (1) | SG184181A1 (pt) |
TW (1) | TWI507193B (pt) |
WO (1) | WO2011120084A1 (pt) |
ZA (1) | ZA201207074B (pt) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10071030B2 (en) | 2010-02-05 | 2018-09-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
CA2794734C (en) | 2010-03-30 | 2017-12-12 | Phosphagenics Limited | Transdermal delivery patch |
WO2012092986A1 (en) | 2011-01-07 | 2012-07-12 | Omya Development Ag | Process for water based mineral material slurry surface whitening |
LT3287123T (lt) | 2011-03-04 | 2020-06-10 | Grünenthal GmbH | Vandeninė farmacinė tapentadolio kompozicija, skirta gerti |
BR112013022556A8 (pt) * | 2011-03-04 | 2018-01-16 | Gruenenthal Gmbh | composição farmacêutica aquosa semissólida contendo tapentadol, seu uso e uso de tapentadol |
EP2685992A4 (en) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | AMINO-QUINOLINES AS KINASE INHIBITORS |
CA2841785A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
CA2790749A1 (en) * | 2011-09-29 | 2013-03-29 | Nitto Denko Corporation | Manufacturing method of patch preparation |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
HRP20211377T1 (hr) | 2011-11-23 | 2022-01-07 | Therapeuticsmd, Inc. | Prirodne kombinirane hormonske supstitucijske formulacije i terapije |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
EP2938391B1 (en) * | 2012-12-28 | 2022-07-27 | Teikoku Seiyaku Co., Ltd. | Extended buprenorphine transdermal delivery compositions |
US9072682B2 (en) * | 2012-12-31 | 2015-07-07 | Mylan Inc. | Transdermal dosage form for low-melting point active agent |
US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
CA2955229C (en) | 2014-07-17 | 2020-03-10 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
CA2951284A1 (en) | 2014-07-29 | 2016-02-04 | Therapeuticsmd, Inc. | Transdermal cream |
KR101688061B1 (ko) * | 2014-10-06 | 2017-01-02 | 주식회사한국파마 | 필로카르핀 경피 흡수 제제 |
EP3209282A4 (en) | 2014-10-20 | 2018-05-23 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
US9375417B2 (en) | 2014-12-04 | 2016-06-28 | Mary's Medicinals LLC | Transdermal cannabinoid formulations |
US10028904B2 (en) | 2014-12-04 | 2018-07-24 | Wisconsin Alumni Research Foundation | Transdermal cannabinoid formulations |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
JP2018511127A (ja) | 2015-03-12 | 2018-04-19 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 渇望入力及び支援システム |
MX2017012312A (es) | 2015-03-27 | 2018-01-18 | Gruenenthal Gmbh | Formulacion estable para administracion parenteral de tapentadol. |
WO2016186201A1 (ja) * | 2015-05-20 | 2016-11-24 | 昭和電工株式会社 | トコフェロールリン酸エステル塩およびその製造方法、皮膚外用剤 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
CN114712308A (zh) | 2015-12-09 | 2022-07-08 | 磷肌酸有限公司 | 药物制剂 |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
JP2019513709A (ja) | 2016-04-01 | 2019-05-30 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | ステロイドホルモン薬学的組成物 |
CN109642137A (zh) | 2016-07-06 | 2019-04-16 | 伊士曼化工公司 | (甲基)丙烯酸系低聚物 |
MX2019003257A (es) | 2016-09-23 | 2019-06-10 | Gruenenthal Gmbh | Formulacion estable para la administracion parenteral de tapentadol. |
KR102499141B1 (ko) * | 2016-10-31 | 2023-02-13 | 신신제약 주식회사 | 수면장애 치료용 경피흡수제제 |
JP2020501606A (ja) * | 2016-12-09 | 2020-01-23 | アベーチョ バイオテクノロジー リミテッド | 動物のパフォーマンスパラメータを改善する方法 |
AU2017381395A1 (en) | 2016-12-21 | 2019-06-20 | Phosphagenics Limited | Process |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
DK3570821T3 (da) | 2017-01-23 | 2021-10-11 | Afyx Therapeutics As | Fremgangsmåde til fremstilling af et tolagsprodukt på basis af elektrospundne fibre |
WO2019004485A1 (ja) * | 2017-06-30 | 2019-01-03 | 富士フイルム株式会社 | 非浸透媒体印刷用前処理液、印刷用基材、印刷用基材の製造方法、画像記録方法及びインクセット |
EP3687510A1 (en) * | 2017-09-27 | 2020-08-05 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
US11160744B2 (en) * | 2017-10-11 | 2021-11-02 | Showa Denko K.K. | Gel composition |
RU2017138097A (ru) * | 2017-11-01 | 2019-05-07 | Анастасия Владимировна Серебрянская | Трансдермальный терапевтический препарат |
BR112020010195A2 (pt) * | 2017-12-20 | 2020-11-03 | Lts Lohmann Therapie-Systeme Ag | composição frigoestável para distribuição transdermal iontoforética de um composto de triptano |
CN108434125B (zh) * | 2018-04-25 | 2020-11-03 | 福州大学 | 一种介孔二氧化硅-胰岛素纳米缓释经皮贴剂的制备方法 |
US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
DE102019120403A1 (de) * | 2019-07-29 | 2021-02-04 | Lts Lohmann Therapie-Systeme Ag | Verfahren zur Herstellung von Haftklebemassen zur Verwendung in einem transdermalen therapeutischen System |
CN112057437B (zh) * | 2019-12-10 | 2021-08-06 | 江苏一全药业有限公司 | 含有透明质酸的药物制剂、药物透皮贴剂及其制备方法 |
GB2608314A (en) * | 2020-02-11 | 2022-12-28 | Babak Ghalili | Cannabinoid and menthol transdermal delivery systems and methods |
AU2021256454A1 (en) * | 2020-04-14 | 2022-09-29 | Glanis Pharmaceuticals, Inc. | Transdermal and/or topical delivery system comprising hydroxychloroquine and/or chloroquine |
MX2022016533A (es) | 2020-06-17 | 2023-04-05 | Psilo Scient Ltd | Composiciones que comprenden compuestos psicoactivos de organismos psicoactivos. |
CA3197443A1 (en) | 2020-12-28 | 2022-06-28 | Psilo Scientific Ltd. | Processes for extracting psychoactive alkaloids and preparation thereof into transmucosal forms |
US11369789B2 (en) | 2021-04-05 | 2022-06-28 | Ishaan Jain | Transdermal drug delivery system |
CN114588133A (zh) * | 2022-03-14 | 2022-06-07 | 南方医科大学深圳医院 | 一种含有羟考酮的皮肤外用止痛贴剂及其制备方法 |
WO2024030855A2 (en) * | 2022-08-01 | 2024-02-08 | Vitamax Patch Wholesaler Llc | Systems and methods for transdermal patch delivery |
KR20240068806A (ko) * | 2022-10-28 | 2024-05-20 | 주식회사 오가시스 | κ-오피오이드 수용체의 아고니스트를 포함하는 피부 미백용 조성물 |
Family Cites Families (262)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2457932A (en) | 1949-01-04 | Salts of tocopheryl phosphoric | ||
US2407823A (en) | 1946-09-17 | Antihemorrhagic esters and methods | ||
US2667479A (en) | 1951-01-30 | 1954-01-26 | Merck & Co Inc | Benzimidazole phosphate |
GB778142A (en) | 1953-11-20 | 1957-07-03 | Leo Ab | High-molecular weight derivatives of hydroxyl group-containing steroids and a method of producing them |
US2913477A (en) | 1957-03-22 | 1959-11-17 | Merck & Co Inc | Antihemorrhagic compounds and processes for preparing the same |
US3127434A (en) | 1959-10-20 | 1964-03-31 | Hoffmann La Roche | Dihydrovitamin k monophosphate compounds and preparation thereof |
US3212901A (en) | 1961-06-07 | 1965-10-19 | Eastman Kodak Co | Stabilized tocopherol concentrates and process for preparing the same |
US3331896A (en) | 1964-09-15 | 1967-07-18 | Gen Aniline & Film Corp | Method of preparing alkali soluble phosphate esters of hydroxylic organic compounds |
US3607765A (en) | 1968-11-29 | 1971-09-21 | Colgate Polmolive Co | Detergent softener compositions |
JPS5239013Y2 (pt) | 1971-10-11 | 1977-09-03 | ||
JPS5022535Y2 (pt) | 1971-11-08 | 1975-07-08 | ||
JPS5315381Y1 (pt) | 1974-06-06 | 1978-04-22 | ||
DE2526938C2 (de) | 1975-02-14 | 1982-04-22 | F. Hoffmann-La Roche & Co. AG, 4002 Basel | Vitaminpräparate |
US4141938A (en) | 1976-10-07 | 1979-02-27 | Hoechst Aktiengesellschaft | Production of acid orthophosphoric acid ester mixtures |
US4444755A (en) | 1978-01-23 | 1984-04-24 | Efamol Limited | Treatment for skin disorders |
US4299906A (en) | 1979-06-01 | 1981-11-10 | American Hoechst Corporation | Light-sensitive color proofing film with surfactant in a light-sensitive coating |
SU925961A1 (ru) | 1980-08-15 | 1982-05-07 | Московский ордена Трудового Красного Знамени технологический институт пищевой промышленности | Способ получени фосфорилированных глицеридов высших жирных кислот |
JPS5944375B2 (ja) | 1981-07-01 | 1984-10-29 | 日本鉱業株式会社 | 溶液中のカルシウムの選択的除去方法 |
US4369172A (en) | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
IT1157269B (it) | 1982-03-19 | 1987-02-11 | Seuref Ag | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica |
JPS58180410U (ja) | 1982-05-28 | 1983-12-02 | 東芝プラント建設株式会社 | 下げ振り |
JPS59157091U (ja) | 1983-04-04 | 1984-10-22 | 日本建鐵株式会社 | 建具用パツキン |
JPS60197621A (ja) | 1984-03-19 | 1985-10-07 | Hohnen Oil Co Ltd | コレステロ−ル低下剤 |
CH661438A5 (it) | 1984-04-09 | 1987-07-31 | Seuref Ag | Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale. |
US4977282A (en) | 1984-04-17 | 1990-12-11 | Henkel Corporation | Production of d-alpha-tocopherol from natural plant sources |
US4603142A (en) | 1984-06-01 | 1986-07-29 | Wisconsin Alumni Research Foundation | Cholesterol lowering method of use |
DE3582904D1 (de) | 1984-08-02 | 1991-06-27 | Henkel Corp | Reinigung von tocopherolen durch extraktion. |
JPS6191137A (ja) | 1984-10-11 | 1986-05-09 | Kao Corp | 外用薬剤組成物 |
JPS6186940U (pt) | 1984-11-12 | 1986-06-07 | ||
JPS6191137U (pt) | 1984-11-19 | 1986-06-13 | ||
JP2540294B2 (ja) | 1985-04-09 | 1996-10-02 | 花王株式会社 | 経皮吸収製剤 |
JPS6220822Y2 (pt) | 1985-04-17 | 1987-05-27 | ||
JPH05946Y2 (pt) | 1985-07-30 | 1993-01-12 | ||
JPS62195393U (pt) | 1986-05-29 | 1987-12-11 | ||
JPS6399150A (ja) | 1986-10-14 | 1988-04-30 | Nippon Steel Corp | 部材の2面反転装置 |
JPH0781138B2 (ja) | 1986-12-02 | 1995-08-30 | 株式会社資生堂 | 抗酸化剤 |
JPS6393791U (pt) | 1986-12-08 | 1988-06-17 | ||
DE3702766A1 (de) | 1987-01-30 | 1988-08-11 | Henkel Kgaa | Verfahren zur herstellung und isolierung von monoalkylphosphorsaeureestern |
JP3070744B2 (ja) | 1987-04-10 | 2000-07-31 | 株式会社日立製作所 | ベクトル処理装置 |
US4952495A (en) | 1987-06-08 | 1990-08-28 | Eastman Kodak Company | Hydrolyzable compounds which release electron transfer agents and analytical use of same |
PH25859A (en) | 1988-01-11 | 1991-12-02 | Takeda Chemical Industries Ltd | Composition for treatment of ischemic disorder |
US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
DE3813624A1 (de) | 1988-04-22 | 1989-11-02 | Basf Ag | Verfahren zur herstellung von d-(alpha)-tocopherol aus natuerlichen vorprodukten |
CA2007643A1 (en) | 1989-02-01 | 1990-08-01 | Donald S. Karanewsky | Combination of an hmg coa reductase inhibitor and a squalene synthetase inhibitor and method for lowering serum cholesterol using such combination |
US6028105A (en) | 1989-04-06 | 2000-02-22 | Nigra; Thomas P. | Topical drug delivery composition and method |
US5053222A (en) | 1989-06-07 | 1991-10-01 | Shiseido Company Ltd. | Hair cosmetic composition |
US5094848A (en) | 1989-06-30 | 1992-03-10 | Neorx Corporation | Cleavable diphosphate and amidated diphosphate linkers |
DE3927113C2 (de) | 1989-08-17 | 1993-11-25 | Dolorgiet Gmbh & Co Kg | Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung |
JPH03120230A (ja) | 1989-10-04 | 1991-05-22 | Nippon Mining Co Ltd | 薬効成分の経皮吸収促進剤及び経皮吸収型製剤 |
JP2854631B2 (ja) | 1989-11-21 | 1999-02-03 | 千寿製薬株式会社 | 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤 |
IT1236843B (it) | 1989-11-22 | 1993-04-21 | Simes | Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati |
JPH03206089A (ja) | 1990-01-05 | 1991-09-09 | Eisai Co Ltd | 新規ビタミンe誘導体及びその製造方法 |
US5374645A (en) | 1990-01-22 | 1994-12-20 | Ciba-Geigy Corporation | Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol |
FR2657526B1 (fr) | 1990-01-31 | 1994-10-28 | Lvmh Rech | Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues. |
US5041434A (en) | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
US5114957A (en) | 1990-05-08 | 1992-05-19 | Biodor U.S. Holding | Tocopherol-based antiviral agents and method of using same |
IE911704A1 (en) | 1990-05-21 | 1991-12-04 | Smith Kline French Lab | Chemical compounds |
JP3765579B2 (ja) | 1990-08-24 | 2006-04-12 | イーデーエーアー アーゲー | 作用物質投与用超微小滴状調剤 |
DE69024370T2 (de) | 1990-10-26 | 1996-06-20 | Shiseido Co Ltd | Hautpräparat zur äusserlichen anwendung |
SE9003665D0 (sv) | 1990-11-16 | 1990-11-16 | Kabivitrum Ab | Morphine prodrugs |
US5646190A (en) | 1991-03-01 | 1997-07-08 | Warner-Lambert Company | Acne treating-wound healing compositions and methods for preparing and using same |
FR2679904A1 (fr) | 1991-08-01 | 1993-02-05 | Lvmh Rech | Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues. |
US5643597A (en) | 1991-08-01 | 1997-07-01 | Lvmh Recherche | Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
EP0535283A1 (en) | 1991-10-02 | 1993-04-07 | Merrell Dow Pharmaceuticals Inc. | Cardioprotective tocopherol analogs |
US5474891A (en) | 1991-10-30 | 1995-12-12 | Thomas Jefferson University | Plasma-based platelet concentrate preparations with additive |
DK0612521T3 (da) | 1991-11-11 | 2000-01-17 | Hisamitsu Pharmaceutical Co | Keterolacholdigt varmt omslag |
EP0543417A1 (en) | 1991-11-22 | 1993-05-26 | Lipogenics, Incorporated | Tocotrienols and tocotrienol-like compounds and methods for their use |
US5282312A (en) | 1991-12-31 | 1994-02-01 | Tessera, Inc. | Multi-layer circuit construction methods with customization features |
WO1993015731A1 (en) | 1992-02-14 | 1993-08-19 | Robert Lamb | Phosphate derivatives of vitamin e to protect cells from effects of aging and injury |
JP3207494B2 (ja) | 1992-04-02 | 2001-09-10 | ロート製薬株式会社 | 水性懸濁製剤 |
JPH05286848A (ja) | 1992-04-10 | 1993-11-02 | Senju Pharmaceut Co Ltd | 浴用剤 |
US5731299A (en) | 1992-05-29 | 1998-03-24 | The Procter & Gamble Company | Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
GB9212450D0 (en) | 1992-06-11 | 1992-07-22 | Indena Spa | New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them |
US5741518A (en) | 1992-08-03 | 1998-04-21 | L'oreal | Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids |
US5773457A (en) | 1995-02-15 | 1998-06-30 | Cesar Roberto Dias Nahoum | Compositions |
AU5171293A (en) | 1992-10-14 | 1994-05-09 | Regents Of The University Of Colorado, The | Ion-pairing of drugs for improved efficacy and delivery |
US5348357A (en) | 1992-12-24 | 1994-09-20 | General Motors Corporation | Vehicle closure latch having plastic coated ratchet |
US6384043B1 (en) | 1993-02-01 | 2002-05-07 | Gholam A. Peyman | Methods of alleviating pain sensations of the denuded eye with opioid analgesics |
TW252918B (pt) | 1993-03-31 | 1995-08-01 | Senju Pharma Co | |
DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
CN1077800C (zh) | 1993-07-01 | 2002-01-16 | 韩美药品工业株式会社 | 环孢菌素软胶囊组合物 |
GB9318271D0 (en) | 1993-09-03 | 1993-10-20 | Scotia Holdings Plc | Tocopherols |
CA2129509A1 (en) | 1993-09-10 | 1995-03-11 | Kazumi Ogata | Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis |
EP0730439A1 (en) | 1993-11-27 | 1996-09-11 | Knoll AG | Compositions comprising iminium ion scavengers and/or nitrite scavengers |
JPH07196516A (ja) | 1993-12-29 | 1995-08-01 | Senju Pharmaceut Co Ltd | 痔疾患治療剤 |
FR2714595B1 (fr) | 1993-12-30 | 1996-02-02 | Oreal | Emulsion eau dans huile contenant du rétinol, son utilisation et son conditionnement. |
FR2715565B1 (fr) | 1994-01-31 | 1996-03-15 | Oreal | Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation. |
EP0669132A1 (en) | 1994-02-23 | 1995-08-30 | van der Kraaij, Antonius Marinus Maria | Pharmaceutical composition of vitamin E and acetylsalicylate for treatment and prevention of atherosclerosis |
CA2145229A1 (en) | 1994-03-29 | 1995-09-30 | Tetsuya Toge | Suppressory compositions against hepatic metastases of tumors |
US5554781A (en) | 1994-03-30 | 1996-09-10 | Reierson; Robert L. | Monoalkyl phosphonic acid ester production process |
JPH07277988A (ja) | 1994-04-05 | 1995-10-24 | Senju Pharmaceut Co Ltd | 局所用掻痒除去、治療剤 |
TW287103B (pt) | 1994-04-22 | 1996-10-01 | Senju Pharma Co | |
JP3362501B2 (ja) | 1994-04-28 | 2003-01-07 | 千寿製薬株式会社 | 角膜障害治療剤 |
JP3396953B2 (ja) | 1994-05-10 | 2003-04-14 | 千寿製薬株式会社 | 網膜疾患予防・治療剤 |
GB9409778D0 (en) | 1994-05-16 | 1994-07-06 | Dumex Ltd As | Compositions |
AU2825295A (en) | 1994-06-13 | 1996-01-05 | Arcturus Pharmaceutical Corporation | Method for the treatment, prevention or minimization of hair loss |
US5589504A (en) | 1994-07-26 | 1996-12-31 | Cornell Research Foundation, Inc. | Treatment of newborn jaundice |
CA2152693A1 (en) | 1994-08-05 | 1996-02-06 | Kazumi Ogata | Therapeutic composition for pancreatitis |
IT1274734B (it) | 1994-08-25 | 1997-07-24 | Prospa Bv | Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti |
HU215966B (hu) | 1994-11-21 | 1999-07-28 | BIOGAL Gyógyszergyár Rt. | Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum |
CN1070495C (zh) | 1994-12-09 | 2001-09-05 | 花王株式会社 | 制备磷酸单酯的方法 |
DE4444238A1 (de) | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden |
SE9404568L (sv) | 1994-12-30 | 1996-07-01 | Perstorp Ab | Användning av inositoltrisfosfat för beredning av läkemedel |
AU4515996A (en) | 1995-01-09 | 1996-07-31 | Alpha-Therapeutics, Inc. | Methods for increasing the bioavailability of biological active agents |
FR2730928B1 (fr) | 1995-02-23 | 1997-04-04 | Oreal | Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique |
JPH08231564A (ja) | 1995-02-28 | 1996-09-10 | Nippon Shokubai Co Ltd | リン酸エステルおよびその製造方法並びにリン酸エステル重合体 |
GB9505025D0 (en) | 1995-03-13 | 1995-05-03 | Medical Res Council | Chemical compounds |
ATE249819T1 (de) | 1995-04-21 | 2003-10-15 | Seikisui Chemical Co Ltd | Präparate zur äusserlichen anwendung zur behandlung von dermatosen |
US5665389A (en) | 1995-05-24 | 1997-09-09 | University Of Maryland At Baltimore | Oral dosage composition for intestinal delivery and method of treating diabetes |
US5607968A (en) | 1995-06-07 | 1997-03-04 | Avon Products, Inc. | Topical alkyl-2-O-L-ascorbyl-phosphates |
KR100423458B1 (ko) | 1995-07-12 | 2004-05-17 | 가부시키가이샤 시세이도 | 피부외용제 |
JP4115524B2 (ja) | 1995-10-17 | 2008-07-09 | 昭和電工株式会社 | 高純度トコフェロールリン酸エステル類、その製造方法、その分析方法並びに化粧料 |
FR2741263B1 (fr) | 1995-11-22 | 1997-12-26 | Oreal | Composition comprenant une dispersion aqueuse de vesicules lipidiques encapsulant un filtre uv a fonction acide et utilisations en application topique |
JP4271730B2 (ja) | 1996-03-27 | 2009-06-03 | インスパイアー ファーマシューティカルズ,インコーポレイティド | ウリジン三リン酸及び関連化合物による線毛ジスキネシアの治療方法 |
US6077828A (en) | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
US5885595A (en) | 1996-05-13 | 1999-03-23 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic composition with a retinol fatty acid ester |
JPH1045783A (ja) | 1996-07-29 | 1998-02-17 | Showa Denko Kk | ヒドロキシクロマン誘導体リン酸エステルの製造方法 |
CA2209690A1 (en) | 1996-07-31 | 1998-01-31 | Sachiko Matsuura | Therapeutic drug for acne vulgaris |
JPH1067639A (ja) | 1996-08-26 | 1998-03-10 | Shiseido Co Ltd | ビタミンe−ビタミンcリン酸ジエステル/シクロデキストリン包接物及び該包接物を配合した皮膚外用剤 |
JPH10155429A (ja) | 1996-11-27 | 1998-06-16 | Showa Denko Kk | 動物に対するビタミンe供給方法および動物用トコフェロールリン酸エステル又はその塩類組成物 |
US6022867A (en) | 1996-11-27 | 2000-02-08 | Showa Denko Kabushiki Kaisha | Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals |
US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US6727280B2 (en) | 1997-01-07 | 2004-04-27 | Sonus Pharmaceuticals, Inc. | Method for treating colorectal carcinoma using a taxane/tocopherol formulation |
US5804168A (en) | 1997-01-29 | 1998-09-08 | Murad; Howard | Pharmaceutical compositions and methods for protecting and treating sun damaged skin |
CN1080112C (zh) | 1997-01-29 | 2002-03-06 | 花王株式会社 | 化妆品 |
KR100563764B1 (ko) | 1997-03-13 | 2006-03-24 | 헥살 아게 | 아미노산과 시클로덱스트린과의 병용에 의한 산(酸) 민감성 벤즈이미다졸류의 안정화 방법 |
US7179486B1 (en) | 1997-04-01 | 2007-02-20 | Nostrum Pharmaceuticals, Inc. | Process for preparing sustained release tablets |
FR2764891B1 (fr) | 1997-06-04 | 2001-04-13 | Pacific Corp | Derive de l'acide l-ascorbique stable dans l'eau, procede pour sa preparation et composition cosmetique de blanchiment de la peau le contenant |
US5928631A (en) | 1997-06-09 | 1999-07-27 | The Procter & Gamble Company | Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins |
US5906811A (en) | 1997-06-27 | 1999-05-25 | Thione International, Inc. | Intra-oral antioxidant preparations |
JPH1143436A (ja) | 1997-07-25 | 1999-02-16 | Showa Denko Kk | 末梢血流障害予防・治療剤 |
US5776915A (en) | 1997-08-12 | 1998-07-07 | Clarion Pharmaceuticals Inc. | Phosphocholines of retinoids |
US6096326A (en) | 1997-08-15 | 2000-08-01 | Scandinavian-American Import/Export Corporation | Skin care compositions and use |
IT1294748B1 (it) | 1997-09-17 | 1999-04-12 | Permatec Tech Ag | Formulazione per un dispositivo transdermico |
JP3950216B2 (ja) | 1997-12-26 | 2007-07-25 | 日本メナード化粧品株式会社 | 皮膚外用剤 |
CA2317008C (en) | 1997-12-31 | 2009-01-20 | The University Of Kansas | Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof |
JPH11199465A (ja) | 1998-01-07 | 1999-07-27 | Nonogawa Shoji Kk | 皮膚外用剤 |
WO1999035242A1 (en) | 1998-01-12 | 1999-07-15 | Betagene, Inc. | Media for neuroendocrine cells |
EP1053749A4 (en) | 1998-02-03 | 2003-01-15 | Senju Pharma Co | PREVENTION AND MEDICINE FOR NEURODEGENERATIVE DISEASES |
FR2777179A1 (fr) | 1998-04-09 | 1999-10-15 | Lvmh Rech | Compositions cosmetiques ou dermatologiques comprenant un vehicule a base d'un liquide hydrophobe |
US6461623B2 (en) | 1998-04-13 | 2002-10-08 | Kao Corporation | Cosmetic composition |
US6254853B1 (en) | 1998-05-08 | 2001-07-03 | Vyrex Corporation | Water soluble pro-drugs of propofol |
JP4208209B2 (ja) | 1998-06-22 | 2009-01-14 | フジノン株式会社 | コリメータレンズおよびこれを用いた光走査装置 |
US6121249A (en) | 1998-07-01 | 2000-09-19 | Donald L. Weissman | Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins |
EP1094781B1 (en) | 1998-07-07 | 2008-07-02 | Transdermal Technologies Inc. | Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
US6204257B1 (en) | 1998-08-07 | 2001-03-20 | Universtiy Of Kansas | Water soluble prodrugs of hindered alcohols |
DE69942342D1 (de) | 1998-09-23 | 2010-06-17 | Res Dev Foundation | Tocopherole, tocotrienole, sonstige chroman- und seitenkettenderivate, sowie deren verwendungen |
US6703384B2 (en) | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
US6770672B1 (en) | 1998-09-23 | 2004-08-03 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
US6153582A (en) | 1998-11-05 | 2000-11-28 | Bausch & Lomb Surgical, Inc. | Defined serumfree medical solution for ophthalmology |
IT1303787B1 (it) | 1998-11-25 | 2001-02-23 | Maria Rosa Gasco | "nanosfere lipidiche solide atte ad una rapida internalizzazione nellecellule" |
US6048891A (en) | 1998-12-17 | 2000-04-11 | Loma Linda University Medical Center | Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease |
AUPQ037499A0 (en) | 1999-05-14 | 1999-06-10 | Swig Pty Ltd | Improved process for phosphorylation and compounds produced by this method |
AUPP829399A0 (en) | 1999-01-25 | 1999-02-18 | Swig Pty Ltd | Recovery for chroman derivatives |
JP2000212082A (ja) | 1999-01-26 | 2000-08-02 | Showa Denko Kk | 皮膚用剤 |
NZ527924A (en) | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
US6156354A (en) | 1999-01-29 | 2000-12-05 | Brandeis University | Hyper-absorption of vitamin E dispersed in milks |
DE19912798C1 (de) | 1999-03-10 | 2000-02-17 | Andreas Jordan | Verfahren zur Kultivierung von Krebszellen aus Humangewebe und Vorrichtung zur Aufbereitung von Gewebeproben |
AU3913800A (en) | 1999-03-26 | 2000-10-16 | Lipogenics, Inc. | Novel antioxidant formulations and methods for using them |
US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
BR0011523B1 (pt) | 1999-05-14 | 2014-09-30 | Vital Health Sciences Pty Ltd | Processo para a fosforilação de um álcool complexo |
DE19922662C1 (de) * | 1999-05-18 | 2000-12-28 | Sanol Arznei Schwarz Gmbh | Transdermales therapeutisches System (TTS) Tolterodin enthaltend |
DE19923551A1 (de) | 1999-05-21 | 2000-11-30 | Lohmann Therapie Syst Lts | Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht |
US6184247B1 (en) | 1999-05-21 | 2001-02-06 | Amway Corporation | Method of increasing cell renewal rate |
AU5594700A (en) | 1999-06-01 | 2000-12-18 | Ocean Spray Cranberries, Inc. | Cranberry seed oil extract and compositions containing components thereof |
JP2003501390A (ja) | 1999-06-04 | 2003-01-14 | ザ ジュネラル ホスピタル コーポレーション | 閉経後及び閉経期の女性を治療するための薬学的製剤、及びそれらの利用 |
NZ517833A (en) | 1999-08-20 | 2004-01-30 | Ferrosan As | Oral delivery of antioxidants vitamin C and vitamin E combinations in slow- and plain-release formulations for treating oxidative stress |
US6669951B2 (en) | 1999-08-24 | 2003-12-30 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into epithelial tissues |
US6423742B1 (en) | 1999-09-02 | 2002-07-23 | Drake Larson | Compositions for reducing vascular plaque formation and methods of using same |
GB9921960D0 (en) | 1999-09-16 | 1999-11-17 | Pharmacia & Upjohn Spa | Formulations for parenteral use of estramustine phosphate and amino acids |
CA2385989A1 (en) | 1999-09-27 | 2001-04-05 | Andrew Nienstedt | Compositions of tocol-soluble therapeutics |
EP1265638A1 (en) | 1999-11-12 | 2002-12-18 | Pharmaderm Laboratories Ltd. | Compositions for transdermal and transmucosal administration of therapeutic agents |
CN100409847C (zh) * | 1999-11-19 | 2008-08-13 | 美国爱科赛尔制药有限公司 | 乌头属生物碱经皮给药系统 |
JP2001169731A (ja) | 1999-12-17 | 2001-06-26 | Showa Denko Kk | 動物体の脂質代謝改善剤 |
AU2335801A (en) | 1999-12-22 | 2001-07-03 | Merck Frosst Canada & Co. | Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
IT1317736B1 (it) * | 2000-01-26 | 2003-07-15 | A C R Applied Coating Res S A | Cerotto per la somministrazione locale e transdermica di principiattivi dotati di gruppi anionici ed elettronattrattori. |
IL151108A0 (en) | 2000-02-11 | 2003-04-10 | Res Dev Foundation | Tocopherols, tocotrienols, other chroman and chain derivatives and uses thereof |
US20030035812A1 (en) | 2000-02-29 | 2003-02-20 | Shinobu Ito | Immune enhancement compositions and use thereof |
US6346544B2 (en) | 2000-03-02 | 2002-02-12 | Oklahoma Medical Research Foundation | Desmethyl tocopherols for protecting cardiovascular tissue |
JP2001247585A (ja) | 2000-03-03 | 2001-09-11 | Nof Corp | トコフェロール誘導体、その中間体、その製造方法及び用途 |
US6444220B2 (en) | 2000-03-16 | 2002-09-03 | Teresa S. Wiley | Method and compositions for changing the contour of skin |
AR027714A1 (es) | 2000-03-24 | 2003-04-09 | Baker Norton Pharma | Uso de sales metalicas para estabilizar composiciones de taxanos. |
US6361800B1 (en) | 2000-04-13 | 2002-03-26 | Cooper Concepts, Inc. | Multi-vitamin and mineral supplement |
FR2811546B1 (fr) | 2000-07-13 | 2003-09-26 | Oreal | Kit et procede de maquillage longue tenue |
US6485950B1 (en) | 2000-07-14 | 2002-11-26 | Council Of Scientific And Industrial Research | Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions |
US6362234B1 (en) | 2000-08-15 | 2002-03-26 | Vyrex Corporation | Water-soluble prodrugs of propofol for treatment of migrane |
KR100365070B1 (ko) | 2000-08-29 | 2002-12-16 | 주식회사 태평양 | 토코페롤 유도체 및 그의 제조방법 |
JP4818500B2 (ja) | 2000-09-05 | 2011-11-16 | 株式会社ペンタプラストア | トコトリエノール誘導体及びその製造方法 |
WO2002026238A1 (en) | 2000-09-26 | 2002-04-04 | Vital Health Sciences Pty Ltd. | Phosphate derivative supplements |
US20030206972A1 (en) | 2000-10-13 | 2003-11-06 | Babish John G. | Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect |
AU2002220021A1 (en) | 2000-11-02 | 2002-05-15 | The Regents Of The University Of California | Alpha-tocopherol transfer protein knockout animals |
AUPR549901A0 (en) * | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
BR0115952B1 (pt) | 2000-11-14 | 2017-10-24 | Vital Health Sciences Pty Ltd | Emulsion composition for therapeutic administration, process for the preparation of a therapeutic formulation and emulsion composition for topical application |
CA2426885C (en) | 2000-11-14 | 2010-06-29 | Vital Health Sciences Pty Ltd | Complexes of phosphate derivatives |
WO2002039996A2 (en) | 2000-11-16 | 2002-05-23 | Pharmacia & Up John Company | Combined therapy against tumors comprising estramustine phosphate and lhrh agonists or antagonists |
WO2002047680A2 (en) | 2000-12-15 | 2002-06-20 | Galileo Laboratories, Inc. | Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia |
US20020151467A1 (en) | 2000-12-21 | 2002-10-17 | Leung Frank K. | Methods and compositions for oral insulin delivery |
US20020131994A1 (en) | 2001-01-10 | 2002-09-19 | Schur Henry B. | Non-irritating formulation for the transdermal delivery of substances |
US6849271B2 (en) | 2001-04-27 | 2005-02-01 | Verion, Inc. | Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods |
TW576859B (en) | 2001-05-11 | 2004-02-21 | Shipley Co Llc | Antireflective coating compositions |
KR100394770B1 (ko) | 2001-06-05 | 2003-08-14 | 주식회사 태평양 | 토코페롤 유도체를 이용하여 나노유화입자를 안정화시키는방법 및 나노유화입자를 함유하는 피부 외용제 조성물 |
CN1547475B (zh) | 2001-07-27 | 2010-12-15 | 生命健康科学有限公司 | 含电子转移试剂的磷酸酯衍生物的皮肤制剂 |
AUPR684801A0 (en) | 2001-08-06 | 2001-08-30 | Vital Health Sciences Pty Ltd | Supplement therapy |
BR0212304A (pt) * | 2001-09-04 | 2004-10-13 | Trommsdorff Arzneimittel | Emplastro para o tratamento de disfunções e desordens de crescimento de unhas |
WO2003024430A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Morphine polymer release system |
EP1429739A1 (en) | 2001-09-21 | 2004-06-23 | Egalet A/S | Polymer release system |
JP2005515969A (ja) | 2001-09-26 | 2005-06-02 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | ビタミン貯蔵の調節 |
AU2002951045A0 (en) | 2002-08-27 | 2002-09-12 | Vital Health Sciences Pty Ltd | Method of supplementing nascent endogenous storage forms |
JP4370451B2 (ja) | 2001-09-28 | 2009-11-25 | 大塚製薬株式会社 | 医薬組成物 |
JP2003128531A (ja) | 2001-10-17 | 2003-05-08 | Nonogawa Shoji Kk | 皮膚外用剤 |
WO2003043570A2 (en) | 2001-11-15 | 2003-05-30 | Galileo Laboratories, Inc. | Formulations and methods for treatment or amelioration of inflammatory conditions |
EP1460995B1 (en) | 2001-12-13 | 2010-11-10 | Vital Health Sciences Pty Ltd. | Transdermal transport of compounds |
WO2003053407A1 (en) | 2001-12-19 | 2003-07-03 | Research Development Foundation | Liposomal delivery of vitamin e based compounds |
CN1522144A (zh) | 2002-01-31 | 2004-08-18 | 关西Tlo株式会社 | 预防人癌症的组合物和预防人癌症的方法 |
US20030220301A1 (en) | 2002-02-14 | 2003-11-27 | Sonus Pharmaceuticals, Inc. | Metformin salts of lipophilic acids |
US7074825B2 (en) | 2002-03-07 | 2006-07-11 | Huanbiao Mo | Composition and method for treating cancer |
WO2003094882A1 (en) | 2002-05-09 | 2003-11-20 | Showa Denko K.K. | Skin whitening external preparation |
EP1507813A4 (en) | 2002-05-20 | 2005-11-23 | Ranbaxy Lab Ltd | FAT BINDING USING AN INTERPOLYMER COMPLEX OF GLUCOSAMINE AND POLYACRYLIC ACID |
US20040018237A1 (en) | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
AU2002950713A0 (en) * | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
US20040067890A1 (en) | 2002-10-04 | 2004-04-08 | Gupta Shyam K. | Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions |
FR2846651B1 (fr) | 2002-10-30 | 2006-06-16 | Rhodia Polyamide Intermediates | Procede de fabrication d'acides carboxyliques |
US7399784B2 (en) | 2002-11-26 | 2008-07-15 | Children's Hospital & Research Center At Oakland | Tocopherol and tocotrienol anti-obesity medicaments |
US6645514B1 (en) | 2002-12-19 | 2003-11-11 | Access Business Group International, Llc | Increasing skin cell renewal with water-soluble Vitamin E |
JP5241995B2 (ja) | 2002-12-31 | 2013-07-17 | トランスダーマル バイオテクノロジ インコーポレーテッド | 安定な局所医薬伝達組成物 |
ATE534384T1 (de) | 2003-01-17 | 2011-12-15 | Vital Health Sciences Pty Ltd | Verbindungen mit proliferationshemmenden eigenschaften |
US7033998B2 (en) | 2003-04-11 | 2006-04-25 | All Natural Fmg, Inc. | Alcohol-free transdermal insulin composition and processes for manufacture and use thereof |
AU2003901815A0 (en) | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphate derivatives |
AU2003901813A0 (en) | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Pharmaceutical derivatives |
AU2003901812A0 (en) | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphates of secondary alcohols |
JP2006199589A (ja) | 2003-09-03 | 2006-08-03 | Ltt Bio-Pharma Co Ltd | 生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤 |
CN100536845C (zh) * | 2003-09-23 | 2009-09-09 | 中国医学科学院药物研究所 | 氯雷他定透皮贴片 |
US7207669B2 (en) | 2003-12-19 | 2007-04-24 | Arizona Chemical Company | Jet printing inks containing polymerized fatty acid-based polyamides |
SI2351555T1 (sl) | 2004-02-23 | 2017-01-31 | Euro-Celtique S.A. | Naprava za transdermalno dajanje opioida, varna pred zlorabo |
US20060281716A1 (en) | 2004-03-03 | 2006-12-14 | West Simon M | Alkaloid formulations |
JP4758347B2 (ja) | 2004-06-29 | 2011-08-24 | 独立行政法人科学技術振興機構 | ヒアルロン酸を用いた小型肝細胞の選択的培養法および分離法 |
NZ553476A (en) | 2004-08-03 | 2010-06-25 | Vital Health Sciences Pty Ltd | Carrier for enteral administration |
US20060120979A1 (en) | 2004-12-02 | 2006-06-08 | Joel Rubin | Skin care composition comprising hydroquinone and a substantially anhydrous base |
WO2006092025A1 (en) | 2005-03-03 | 2006-09-08 | Vital Health Sciences Pty Ltd | Compounds having lipid lowering properties |
JP2008531602A (ja) | 2005-03-03 | 2008-08-14 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 抗癌特性を有する化合物 |
US20090239827A1 (en) | 2005-03-03 | 2009-09-24 | Esra Ogru | Compounds having lipid lowering properties |
JP4270212B2 (ja) | 2005-03-29 | 2009-05-27 | セイコーエプソン株式会社 | 基板間隔調整装置、基板間隔調整方法、および液晶表示装置の製造方法 |
US20060228395A1 (en) | 2005-04-11 | 2006-10-12 | Robert Lamb | Vitamin E phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage |
CN101247834B (zh) * | 2005-06-17 | 2013-10-30 | 生命健康科学公司 | 包含一种或多种二-和/或单-(电子转移剂)磷酸酯衍生物或其络合物的载体 |
NZ565049A (en) * | 2005-06-17 | 2012-02-24 | Vital Health Sciences Pty Ltd | A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
KR100764679B1 (ko) * | 2005-07-22 | 2007-10-09 | 익수제약 주식회사 | 파록세틴을 함유하는 경피투여용 패취제 |
US7446096B2 (en) | 2005-12-19 | 2008-11-04 | Industrial Technology Research Institute | Glutathione based delivery system |
TW200800223A (en) | 2005-12-21 | 2008-01-01 | Shire Pharmaceuticals Inc | Transdermal delivery of meptazinol |
CA2631653A1 (en) | 2005-12-23 | 2007-06-28 | Vital Health Sciences Pty Ltd. | Compounds having cytokine modulating properties |
WO2008034178A1 (en) | 2006-09-21 | 2008-03-27 | Salvatore Iemma | Topical depilating composition |
RU2373957C2 (ru) | 2006-10-13 | 2009-11-27 | Александр Метталинович Тишин | Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его |
JP5201858B2 (ja) | 2007-03-26 | 2013-06-05 | 花王株式会社 | 遊離脂肪酸が低減された油脂の製造方法 |
FR2921259B1 (fr) | 2007-09-26 | 2015-02-13 | Lvmh Rech | Utilisation cosmetique du phosphate de tocopherol comme agent anti-vieillissement de la peau |
EP2113242A1 (en) | 2008-05-02 | 2009-11-04 | Pangaea Laboratories Limited | Antioxidant for use in cosmetic, medicated and pharmaceutical preparations |
US20090297591A1 (en) | 2008-05-30 | 2009-12-03 | Orient Pharma Co., Ltd. | Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds |
EP2516011B1 (en) | 2009-12-23 | 2017-07-12 | Phosphagenics Limited | Carrier composition for delivery of a biologically active compound |
SG182836A1 (en) | 2010-02-05 | 2012-09-27 | Phosphagenics Ltd | Carrier composition |
US10071030B2 (en) | 2010-02-05 | 2018-09-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
JP5132700B2 (ja) | 2010-02-22 | 2013-01-30 | 三菱電機株式会社 | 手乾燥装置 |
CA2794734C (en) * | 2010-03-30 | 2017-12-12 | Phosphagenics Limited | Transdermal delivery patch |
EP2685992A4 (en) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | AMINO-QUINOLINES AS KINASE INHIBITORS |
-
2011
- 2011-03-30 CA CA2794734A patent/CA2794734C/en active Active
- 2011-03-30 US US13/501,500 patent/US8652511B2/en active Active
- 2011-03-30 RU RU2012141586/15A patent/RU2553350C2/ru active
- 2011-03-30 ES ES11761826T patent/ES2829386T3/es active Active
- 2011-03-30 JP JP2013501560A patent/JP5806287B2/ja active Active
- 2011-03-30 AU AU2011235597A patent/AU2011235597B2/en active Active
- 2011-03-30 CN CN201180017569.3A patent/CN102821791B/zh active Active
- 2011-03-30 WO PCT/AU2011/000358 patent/WO2011120084A1/en active Application Filing
- 2011-03-30 BR BR112012024835A patent/BR112012024835A2/pt not_active IP Right Cessation
- 2011-03-30 NZ NZ602572A patent/NZ602572A/en unknown
- 2011-03-30 EP EP11761826.4A patent/EP2552486B1/en active Active
- 2011-03-30 TW TW100111019A patent/TWI507193B/zh not_active IP Right Cessation
- 2011-03-30 MX MX2012011355A patent/MX2012011355A/es active IP Right Grant
- 2011-03-30 SG SG2012069993A patent/SG184181A1/en unknown
- 2011-03-30 KR KR1020127025679A patent/KR20130010473A/ko not_active Application Discontinuation
-
2012
- 2012-09-20 ZA ZA2012/07074A patent/ZA201207074B/en unknown
- 2012-09-27 IL IL222226A patent/IL222226A/en active IP Right Grant
-
2013
- 2013-11-21 US US14/086,738 patent/US20140155495A1/en not_active Abandoned
-
2014
- 2014-11-21 US US14/550,514 patent/US9314527B2/en active Active
-
2016
- 2016-03-09 US US15/065,510 patent/US20160184436A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN102821791B (zh) | 2015-06-17 |
US20140155495A1 (en) | 2014-06-05 |
CA2794734A1 (en) | 2011-10-06 |
TW201201796A (en) | 2012-01-16 |
TWI507193B (zh) | 2015-11-11 |
JP5806287B2 (ja) | 2015-11-10 |
JP2013523660A (ja) | 2013-06-17 |
US20160184436A1 (en) | 2016-06-30 |
US9314527B2 (en) | 2016-04-19 |
US20150148431A1 (en) | 2015-05-28 |
IL222226A (en) | 2017-04-30 |
ES2829386T3 (es) | 2021-05-31 |
IL222226A0 (en) | 2012-12-31 |
MX2012011355A (es) | 2012-11-30 |
AU2011235597A1 (en) | 2012-10-18 |
AU2011235597B2 (en) | 2015-07-16 |
US20120201891A1 (en) | 2012-08-09 |
NZ602572A (en) | 2014-11-28 |
CN102821791A (zh) | 2012-12-12 |
KR20130010473A (ko) | 2013-01-28 |
RU2553350C2 (ru) | 2015-06-10 |
EP2552486A1 (en) | 2013-02-06 |
RU2012141586A (ru) | 2014-04-10 |
ZA201207074B (en) | 2013-05-29 |
SG184181A1 (en) | 2012-10-30 |
CA2794734C (en) | 2017-12-12 |
EP2552486B1 (en) | 2020-08-12 |
EP2552486A4 (en) | 2014-07-09 |
US8652511B2 (en) | 2014-02-18 |
WO2011120084A1 (en) | 2011-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012024835A2 (pt) | adesivo de distribuição transdérmica | |
GT201200321A (es) | Derivados de heteroaril imidazolona como inhibidores de jak | |
WO2011100425A3 (en) | Methods and compositions for wound healing | |
CL2013000018A1 (es) | Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros. | |
CL2008001633A1 (es) | Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer. | |
CY1116638T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας | |
MY168166A (en) | Polymer and Composition Including Same, and Adhesive Composition | |
BR112015009189A2 (pt) | conjunto de potência para um autoinjetor e autoinjetor que contém o mesmo | |
EA201000747A1 (ru) | Система и способ трансдермальной доставки и способ получения системы трансдермальной доставки | |
EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
MX2015008286A (es) | Composiciones multipolimericas para liberación transdermica de farmaco. | |
EA201290888A1 (ru) | Фармацевтическая композиция, содержащая производное пиримидинона | |
BR112015028703A2 (pt) | curativo de ferimentos compreendendo uma composição antimicrobiana | |
MY163809A (en) | Transdermal drug delivery system containing donepezil | |
BR112012027545A2 (pt) | composto de fórmula i, composição farmacêutica, uso da composição farmacêutica, uso de um composto e método de modulação do nível de glicose no sangue em um indivíduo | |
PH12015501982A1 (en) | Pharmaceutical compositions comprising everolimus | |
MX2013002329A (es) | Agonista de receptores de neutrofina y sus usos como medicamentos. | |
SV2010003752A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
WO2008116004A3 (en) | Transdermal patch and method for delivery of vitamin b12 | |
MX341642B (es) | Composicion de liberacion sostenida que contiene peptidos como ingredientes activos. | |
CL2012002543A1 (es) | Composicion endoparasiticida que comprende una combinacion de un compuesto de formula (i) derivado de amidoacetonitrilo y abamectina; y su uso para el control de endoparasitos, en particular helmintos. | |
WO2012111996A3 (ko) | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 | |
MX2013004711A (es) | Composiciones farmaceuticas. | |
CU20130124A7 (es) | Derivados de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritmia | |
SG11201501954SA (en) | Low molecular weight branched polyamines for delivery of biologically active materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2560 DE 28/01/2020. |